Table 2 |
||||||
|
Characteristics and serum FSTL1 levels in the subjects investigateda. |
||||||
|
HC |
OA |
Male HC |
Male OA |
Female HC |
Female OA |
|
|
|
||||||
|
Number |
63 |
168 |
29 |
48 |
34 |
120 |
|
Age (years)b |
37 (29-47) |
62 (54-69) |
35 (31-43) |
61 (54-72) |
39 (29-52) |
62 (54-69) |
|
Disease duration (years)b |
- |
1.0 (0.3-3.9) |
- |
0.5 (0.2-3.0) |
- |
1.0 (0.5-5.0) |
|
FSTL1 levels (μg/L)b |
2.93 |
19.03 |
2.50 |
5.64 |
3.32 |
24.40 |
|
(2.35-3.69) |
(7.41-27.98) |
(2.17-2.96) |
(3.81-8.75) |
(2.43-8.67) |
(15.65-31.17) |
|
|
|
||||||
|
aIncluded all subjects for whom serum samples were available. bExpressed as the median (25th to 75th percentile). FSTL1: follistatin-like protein 1; HC: healthy control individual; OA: osteoarthritis. |
||||||
|
Wang et al. Arthritis Research & Therapy 2011 13:R193 doi:10.1186/ar3522 |
||||||
